Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122726) titled 'Intrathecal Morphine for Pain Relief and Recovery After Uterine Artery Embolization' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Condition:
Uterine fibroids and adenomyosis
Intervention:
Intrathecal Placebo + Standard Postoperative Care:Intrathecal Placebo
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Intrathecal Placebo + Standard Postoperative Care:60;Intrathecal Morphine + Standard Postoperative Care:60;
Countries ...